Estrella Immunopharma, Inc.
ESLA
$1.15
$0.021.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.25M | -13.06M | -13.50M | -12.08M | -10.48M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 753.40K | 657.20K | 970.00K | 750.50K | 591.40K |
| Change in Net Operating Assets | 4.48M | 10.62M | 10.03M | 7.33M | 6.02M |
| Cash from Operations | -8.02M | -1.79M | -2.50M | -3.99M | -3.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.40M | 2.40M | 2.48M | 1.43M | 79.50K |
| Repurchase of Common Stock | 0.00 | -29.50K | -93.50K | -244.00K | -514.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -876.40K | -117.50K | -52.70K | -40.00K | -- |
| Cash from Financing | 9.52M | 2.25M | 2.33M | 1.15M | -434.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.51M | 467.40K | -170.90K | -2.85M | -4.31M |